BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36027610)

  • 1. Recent advances in the therapeutic potential of emodin for human health.
    Sharifi-Rad J; Herrera-Bravo J; Kamiloglu S; Petroni K; Mishra AP; Monserrat-Mesquida M; Sureda A; Martorell M; Aidarbekovna DS; Yessimsiitova Z; Ydyrys A; Hano C; Calina D; Cho WC
    Biomed Pharmacother; 2022 Oct; 154():113555. PubMed ID: 36027610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the journey of emodin as a potential neuroprotective agent: Novel therapeutic insights with molecular mechanism of action.
    Mitra S; Anjum J; Muni M; Das R; Rauf A; Islam F; Bin Emran T; Semwal P; Hemeg HA; Alhumaydhi FA; Wilairatana P
    Biomed Pharmacother; 2022 May; 149():112877. PubMed ID: 35367766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin and Its Role in Chronic Diseases.
    Monisha BA; Kumar N; Tiku AB
    Adv Exp Med Biol; 2016; 928():47-73. PubMed ID: 27671812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of Emodin for Gastrointestinal Cancers.
    McDonald SJ; VanderVeen BN; Velazquez KT; Enos RT; Fairman CM; Cardaci TD; Fan D; Murphy EA
    Integr Cancer Ther; 2022; 21():15347354211067469. PubMed ID: 34984952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of emodin in atherosclerosis and other cardiovascular diseases: Pharmacological effects, mechanisms, and potential therapeutic target as a phytochemical.
    Wang X; Yang S; Li Y; Jin X; Lu J; Wu M
    Biomed Pharmacother; 2023 May; 161():114539. PubMed ID: 36933375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer.
    Okon E; Gaweł-Bęben K; Jarzab A; Koch W; Kukula-Koch W; Wawruszak A
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics.
    Dong X; Fu J; Yin X; Cao S; Li X; Lin L; ; Ni J
    Phytother Res; 2016 Aug; 30(8):1207-18. PubMed ID: 27188216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reynoutria Japonica from Traditional Chinese Medicine: A Source of Competitive Adenosine Deaminase Inhibitors for Anticancer.
    Zhang XG; Ma GY; Kou F; Liu WJ; Sun QY; Guo GJ; Ma XD; Guo SJ; Jian-Ning Z
    Comb Chem High Throughput Screen; 2019; 22(2):113-122. PubMed ID: 30987561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin.
    Cui Y; Chen LJ; Huang T; Ying JQ; Li J
    Chin J Nat Med; 2020 Jun; 18(6):425-435. PubMed ID: 32503734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin - A natural anthraquinone derivative with diverse pharmacological activities.
    Semwal RB; Semwal DK; Combrinck S; Viljoen A
    Phytochemistry; 2021 Oct; 190():112854. PubMed ID: 34311280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms.
    Hu Y; Yang L; Lai Y
    Biomed Pharmacother; 2023 Jun; 162():114585. PubMed ID: 36989724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional uses, phytochemistry, and pharmacology of Persicaria orientalis (L.) Spach - A review.
    Gou KJ; Zeng R; Ma Y; Li AN; Yang K; Yan HX; Jin SR; Qu Y
    J Ethnopharmacol; 2020 Mar; 249():112407. PubMed ID: 31751652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers.
    Zhang Q; Chen WW; Sun X; Qian D; Tang DD; Zhang LL; Li MY; Wang LY; Wu CJ; Peng W
    Int J Biol Sci; 2022; 18(8):3498-3527. PubMed ID: 35637953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin in atherosclerosis prevention: Pharmacological actions and therapeutic potential.
    Luo N; Fang J; Wei L; Sahebkar A; Little PJ; Xu S; Luo C; Li G
    Eur J Pharmacol; 2021 Jan; 890():173617. PubMed ID: 33010303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin in cardiovascular disease: The role and therapeutic potential.
    Guo Y; Zhang R; Li W
    Front Pharmacol; 2022; 13():1070567. PubMed ID: 36618923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of emodin on liver disease -- comprehensive advances in molecular mechanisms.
    Hu N; Liu J; Xue X; Li Y
    Eur J Pharmacol; 2020 Sep; 882():173269. PubMed ID: 32553811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Progress and New Perspectives of Anticancer Effects of Emodin.
    Liu W; Qaed E; Zhu Y; Tian W; Wang Y; Kang L; Ma X; Tang Z
    Am J Chin Med; 2023; 51(7):1751-1793. PubMed ID: 37732372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent.
    Srinivas G; Babykutty S; Sathiadevan PP; Srinivas P
    Med Res Rev; 2007 Sep; 27(5):591-608. PubMed ID: 17019678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin in
    Lee EH; Baek SY; Park JY; Kim YW
    Pharm Biol; 2020 Dec; 58(1):333-341. PubMed ID: 32306810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.